Q4 2025 Earnings Call February 24, 2026 7:01 PM ESTCompany ParticipantsRyan Kolln - CEO, MD & DirectorJustin Miles - ...
Arcus Biosciences (NYSE:RCUS) used its fourth-quarter and full-year 2025 earnings call to highlight updated clinical data for its lead oncology program, casdatifan, and to outline near-term plans for ...
The cost of healthcare in the United States is on the rise in a big way. In its 2026 healthcare outlook, the Big Four accounting firm PricewaterhouseCoopers (PwC) made strong statements confirming ...
Annual Neudata report estimates 2025 spend rose 17% to $2.8bn, finds firms are using AI mainly for productivity vs investment optimisation, and highlights less "crowding" on average per dataset.LONDON ...
Rail Vision Ltd. (Nasdaq: RVSN) ("Rail Vision" or the "Company"), an early commercialization stage technology company focused on transforming railway ...